Czechia – Pharmaceutical products – J01CR01 AMPICILIN A INHIBITOR BETA-LACTAMASY
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the public contract is the continuous supply of medicines containing the active substance J01CR01 AMPICILIN AND BETA-LACTAMASE INHIBITOR for a period of 4 years. The contracting authority only requires medicinal products for which the amount of reimbursement from public health insurance has been determined by the State Institute for Drug Control, or medicinal products that are included in the so-called N-DRUG code list issued by the General Medical Insurance Company of the Czech Republic and the Association of Medical Insurance Companies, which include hospital medications and insurance companies guarantee reimbursement for them. A contract for a duration of 4 years is concluded with the winning participant.